Archived ASX Announcements


 
    LODGMENT OF COURT ORDERS WITH ASIC  
 
    Suspension from Official Quotation (COB 20/11/2017)  
 
    COURT APPROVES SCHEME OF ARRANGEMENT  
 
    Substituted annexure to announcement re Scheme Meeting  
 
    AMENDED ANNEXURE TO ANNOUNCEMENT RE SCHEME MEETING  
 
    MLA SHAREHOLDERS APPROVE SCHEME  
 
    Appendix 4C - quarterly  
 
    2017 Annual General Meeting - Advice of ASIC Relief  
 
    DISPATCH OF SCHEME BOOKLET TO SHAREHOLDERS  
 
    Scheme Booklet Registered with ASIC  
 
    Court approves Scheme Booklet and Convening of Meeting  
 
    APPENDIX 4G  
 
    Annual Report to shareholders  
 
    Scheme Of Arrangement Update  
 
    APPENDIX 4E AND PRELIMINARY FINAL REPORT  
 
    MLA & ICU MEDICAL INC SIGNS SCHEME IMPLEMENTATION AGREEMENT  
 
    Appendix 4C March 2017 Quarter  
 
    Half Yearly Report and Accounts  
 
    Ardo Breast Pump Agreement  
 
    Change in substantial holding  
 
    Product Update  
 
    Change in substantial holding  
 
    Quarterly Report  
 
    Appendix 4C - quarterly  
 
    Change in substantial holding  
 
    Results of Meeting  
 
    Quarterly Report  
 
    Appendix 4C - quarterly  
 
    Notice of Annual General Meeting  
 
    Appendix 4G  
 
    Annual Report 2016  
 
    Preliminary Final Report  
 
    Change in substantial holding  
 
    Appendix 4C - quarterly  
 
    Quarterly Cashflow Report  
 
    Change of Share Registry address  
 
    Distribution Agreement with Ardo  
 
    Change in substantial holding  
 
    Change in substantial holding  
 
    Appendix 4C and Commentary  
 
    Medical Australia Limited Interim Financial Report  
 
    Response to ASX Appendix 4C Query  
 
    Exclusive Distribution Rights for DuelCap System Secured  
 
    Appendix 4C - 31 December 2015  
 
    Quarterly Report - December 2015  
 
    MLA Finalises Sale of MediVet  
 
    Release of Restricted Securities from Voluntary Escrow  
 
    Medivet Biologics US Animal Health Business  
 
    Results of Annual General Meeting  
 
    Notice of AGM & Explanatory Memorandum  
 
    Appendix 4G  
 
    Annual Report 2015  
 
    Revenue Report for Year Ended 30 June 2015  
 
    Appendix 4E - 30 June 2015  
 
    Appendix 4C - 30 June 2015  
 
    Quarterly Report - 30 June 2015  
 
    Change of Share Registry Name  
 
    Focus on Human Healthcare & Dilution of Animal Business  
 
    Appendix 4C - 31 March 2015  
 
    Quarterly Report - 31 March 2015  
 
    Notice of Change of Interests of Substantial Holde  
 
    Form 603 - Notice of Initial Substantial Holder  
 
    Terms of Incentive Share Scheme - CEO  
 
    Half Yearly Commentary  
 
    Half Year Report for Period Ended 31 December 2014  
 
    Quarterly Report and Appendix 4C - 31 December 2014  
 
    Updated Contact Details for Share Registry  
 
    MLA Subsidiary to help Develop Canine Cancer Treatment  
 
    Terms of Appointment of CEO  
 
    Release of Restricted Securities from Voluntary Escrow  
 
    Darryl Ellis appointed as CEO of Medical Australia Limited  
 
    Release of Restricted Securities from Voluntary Escrow  
 
    Notice of Initial Substantial Holder - Pie Funds Management  
 
    Becoming a substantial holder  
 
    Change in substantial holding  
 
    Change in substantial holding notices  
 
    Notice in Accordance with the Corporations Act 2001  
 
    Amended Number of Shares Issued Pursuant to Rights Issue  
 
    Further Amended Notification of Under-Subscriptions  
 
    Shares Listed Pursuant to Non-Renounceable Rights Issue  
 
    Amended Notification of Under-Subscriptions - Rights Issue  
 
    Appendix 3Y - Ian Mitchell  
 
    Notification of Under-Subscriptions - Rights Issue  
 
    Results of Annual General Meeting  
 
    Appendix 4C - 30.9.14  
 
    Quarterly Report - September 2014  
 
    Non-Renounceable Rights Issue Offer Document  
 
    Appendix 3B  
 
    Notice of Intention to Offer a Rights Issue  
 
    Letter to All Shareholders - Rights Issue  
 
    Notice of Annual General Meeting  
 
    Annual Report 2014  
 
    Appendix 4E - 30 June 2014  
 
    Retirement of Chairman  
 
    Appendix 3B  
 
    MLA Appoints Dr Amy Crouch as National Veterinary Manager  
 
    Quarterly Report - 30 June 2014  
 
    Appendix 4C  
 
    MediVet Successful in out of Court Settlement  
 
    MLA licensed for distribution of nanofiber animal technology  
 
    Appendix 3Y- Mitchell  
 
    Appendix 3Y- Mitchell  
 
    Appendix 3B  
 
    Quarterly Report & Appendix 4C - March 2014  
 
    Appendix 4D & Half-Yearly Report  
 
    Appendix 3X - Jeremy Delk  
 
    Appointment of Jeremy Delk as a Director  
 
    Change of Share Registry  
 
    Amended Appendix 3X  
 
    Amendment to Announcement Dated 13 February 2014  
 
    Appendix 3X - Hancox  
 
    Appendix 3Z - Donnison  
 
    Board and Management Changes  
 
    Notice of Initial Substantial Holder  
 
    Quarterly Report December 2013  
 
    Appendix 4C  
 
    Response to ASX Price Query Letter  
 
    Change in substantial holding  
 
    Becoming a substantial holder  
 
    Becoming a substantial holder  
 
    Becoming a substantial holder  
 
    Becoming a substantial holder  
 
    Becoming a substantial holder  
 
    MLA Raises $4 Million To Fast Track Growth  
 
    Appendix 3B  
 
    Appendix 3B  
 
    Results of Annual General Meeting  
 
    Change of Principal Place of Business  
 
    Notice to Shareholders  
 
    Notice of Annual General Meeting  
 
    Appendix 4C  
 
    Annual Report 2013  
 
    MLA signs agreement to acquire MediVet  
 
    Appendix 4E  
 
    Appendix 3Y - Mitchell  
 
    Appendix 4C - Quarter June 2013  
 
    Amended Results of General Meeting - 15 July 2013  
 
    Results of General Meeting - 15 July 2013  
 
    Consolidation of Shares Proposal - Amended Timetable  
 
    Amended Appendix 3Y - Donnison  
 
    Investor Presentation  
 
    Independent Expert's Report  
 
    Notice of General Meeting and Explanatory Memorandum  
 
    Appendix 3Y  
 
    Appendix 3Y  
 
    MLA Announces Acquisition of Medivet  
 
    Amended Appendix 4C  
 
    Appendix 4C  
 
    MLA Expands OEM Agreements  
 
    MLA strengthens UK presence with NHS Trust Supply Agreement  
 
    Half Year Report  
 
    Response to ASX Query - Appendix 4C  
 
    Appendix 4C  
 
    Update on Sales and Marketing of FirstFlow Burette  
 
    Results of Annual General Meeting  
 
    Appendix 4C  
 
    Notice of Annual General Meeting  
 
    2012 Annual Report and Notice of AGM sent to Shareholders  
 
    Annual Report 2012  
 
    Amended Appendix 3X  
 
    Appendix 4E  
 
    Appendix 4C  
 
    COMMENCEMENT OF SALES OF TUTA BURETTES WITH MEDIAFLUSH tm  
 
    Appendix 3Y  
 
    Appendix 3Y  
 
    Appendix 3B  
 
    MLA successfully completes first animal stem cell treatment  
 
    Appendix 4C  
 
    BRR Interview  
 
    MLA first in Europe to cryogenically freeze stem cells  
 
    Appendix 4D  
 
    Appendix 4C  
 
    Update to independent research report on MLA  
 
    Appendix 3X  
 
    Appointment of Chairman  
 
    Appendix 3Z  
 
    Death of Chairman of the Company  
 
    MLA secures over $1.5 million in new supply agreements  
 
    Boardroom Radio Webcast  
 
    Change of Share Registry  
 
    Results of Annual General Meeting  
 
    MLA reports first quarter revenue of $3 million  
 
    Appendix 4C  
 
    Annexure to Notice of Annual General Meeting  
 
    Notice of Annual General Meeting  
 
    Notice to Shareholders - Annual Report and AGM  
 
    Share Trading Policy  
 
    Share Trading Policy  
 
    Annual Report  
 
    MLA launches American Depositary Receipt Program  
 
    Appendix 3B  
 
    Boardroom Radio Broadcast  
 
    MLA secures new distribution agreement  
 
    Appendix 4E Commentary  
 
    Appendix 4E  
 
    MLA well funded in cash following Option Conversion  
 
    Appendix 4C - quarterly  
 
    Option Issue Shortfall  
 
    Appendix 3B  
 
    Supply Agreement for Analytica  
 
    Appendix 3B  
 
    Secures Master Distributorship for MediVet in UK  
 
    Final Director`s Interest Notice  
 
    Initial Director`s Interest Notice  
 
    Director Appointment/Resignation  
 
    Change of Director`s Interest Notice  
 
    Change of Director`s Interest Notice  
 
    Change of Director`s Interest Notice  
 
    Amended Appendix 3Y  
 
    Appendix 3Y  
 
    Appendix 3Y  
 
    Notice to Holders  
 
    Appointment of Underwriter  
 
    New supply contract with UNICEF  
 
    Independent research report on MLA  
 
    Appendix 4C  
 
    New supply agreement with Healthscope  
 
    Appendix 3B  
 
    MLA secures new distribution agreement with Haemonetics  
 
    Appendix 3Y  
 
    Appendix 3Y  
 
    Appendix 3Y  
 
    Amended Appendix 3B  
 
    Appendix 3B  
 
    MLA report maiden NPAT with growth continuing  
 
    Appendix 4D  
 
    Appendix 3Y  
 
    Appendix 3Y  
 
    Appendix 4C  
 
    MLA delivers 18% increase in half year revenue to $4.6 mill  
 
    Amended Appendix 3Y  
 
    Appendix 3Y  
 
    Medical Australia Limited Broadcast  
 
    Landmark OEM agreement with leading global medical device co  
 
    Appendix 3B  
 
    Securities Trading Policy  
 
    Update on Care Essentials and Placement of Shortfall  
 
    Three year OEM supply agreement with Terumo Medical Corp  
 
    Notice in accordance with Section 1012DA(5)(e)  
 
    Appendix 3B  
 
    Results of Annual General Meeting  
 
    Presentation  
 
    Amended Appendix 3Y  
 
    Appendix 3Y  
 
    Broadcast  
 
    MLA reports record first quarter performance  
 
    Appendix 4C  
 
    Notice of Annual General Meeting and Proxy Form  
 
    Notice to Shareholders  
 
    Appendix 3Y  
 
    Appendix 3B  
 
    Annual Report for year ended 30 June 2010  
 
    Appendix 3Y  
 
    Appendix 3B  
 
    Amended Appendix 3Y  
 
    Appendix 3Y  
 
    Appendix 3Y  
 
    Appendix 3Y  
 
    Appendix 3Y  
 
    Update on Care Essentials Transaction  
 
    Appendix 4E  
 
    Appendix 3Y  
 
    Appendix 3B  
 
    Appendix 3Y  
 
    Notification of Under Subscription Rights Issue  
 
    Despatch of offers non-renounceable rights issue  
 
    Appendix 4C  
 
    Medical Australia Limited Broadcast  
 
    Results of General Meeting  
 
    MLA secures multi-million dollar global agreement - Medivet  
 
    MLA signs contract for Care Essentials acquisition  
 
    Notice of General Meeting  
 
    Replacement Prospectus  
 
    Amended Appendix 3B  
 
    Replacement Prospectus  
 
    Amended Appendix 3B  
 
    Appendix 3B  
 
    Rights Issue Prospectus  
 
    Release of restricted securities from voluntary escrow  
 
    Appendix 3Y  
 
    Appendix 4C  
 
    Appendix 3B  
 
    MLA and ALT sign licensing and distribution agreement  
 
    MLA acquires leading medical products business  
 
    Release from Restricted Securities  
 
    Amended Appendix 3B  
 
    Appendix 3B  
 
    Appendix 3Z-Mann  
 
    Appendix 3X - Hartigan  
 
    MLA strengthens board and senior leadership  
 
    Appendix 4D and Half Yearly Report  
 
    Appendix 3Y  
 
    Appendix 3Y  
 
    Appendix 4C  
 
    Amended Appendix 3B  
 
    Appendix 3B  
 
    MLA and ALT sign Licensing and Distribution HOA  
 
    Appendix 4C  
 
    Change of Company Name  
 
    Results of Annual General Meeting 23 October 2009  
 
    BMDI Tuta Enters UK Market with 5 Year Supply Agreement  
 
    BMDI Tuta Posts Strong First Quarter Sales  
 
    Appendix 3B  
 
    Online Annual Report Notice  
 
    Notice of Annual General Meeting  
 
    Annual Report  
 
    2009 Annual Report and Notice of AGM Letter  
 
    BMDI Tuta Delivers Revenue Growth  
 
    Appendix 4E  
 
    Response to ASX Query re Appendic 4C  
 
    Appendix 4C - Quarterly Report - BMDI Tuta Limited  
 
    BMDI Tuta well positioned for next stage of growth  
 
    Notice in Accordance with Section 1012DA(5)(e)  
 
    Appendix 3B  
 
    Notice if Accordance with Section 1012DA(5)(e)  
 
    Notification of under-subscriptions re Rights Issue  
 
    Appendix 3Y - Cumming  
 
    Appendix 4C  
 
    ASX Circular: Rights Issue Timetable  
 
    Despatch of Offer Document  
 
    Offer Document  
 
    REINSTATEMENT TO OFFICIAL QUOTATION  
 
    Announcement - Rights Issue  
 
    Appendix 3B  
 
    Suspension from Official Quotation  
 
    Trading Halt  
 
    Acqusition Of Clements Medical Equipment  
 
    Half Yearly Report Announcement  
 
    Announcement Half Yearly  
 
    Half Yearly Report  
 
    Response to ASX Query regarding Appendix 4C  
 
    Appendix 4C  
 
    Initial Director`s Interest Notice  
 
    Changes to Board and Management team  
 
    Change of Director`s Interest Notice  
 
    Change of Share Registry  
 
    Results of Annual General Meeting  
 
    Annual General Meeting Presentation  
 
    Appendix 3Z - Final Director`s Interest Notice  
 
    Board Composition  
 
    BMDI Tuta Reports Record Quarterly Sales  
 
    Appendix 4C - Quarterly Report  
 
    Nomination of Auditor  
 
    Correction to Notice of Annual General Meeting  
 
    Annual Report 2008  
 
    Notice of Annual General Meeting  
 
    Change of Address Details  
 
    Resignation of Nightingale and Appointment of Mitchell  
 
    Full Year Statutory Accounts  
 
    Preliminary Final Report  
 
    Details of Company Address  
 
    Response to ASX Appendix 4C Query  
 
    Change in substantial holding  
 
    Appendix 4C - quarterly  
 
    Change of Director`s Interest Notice  
 
    Change of Director`s Interest Notice  
 
    Final Director`s Interest Notice  
 
    Passing away of Chairman Keith Cadell  
 
    Change of Director`s Interest Notice  
 
    Change of Director`s Interest Notice  
 
    Becoming a substantial holder  
 
    Change of Director`s Interest Notice  
 
    Becoming a substantial holder  
 
    Appendix 4C - quarterly  
 
    Resignation of a Director and Appendix 3Z  
 
    Change of Director`s Interest Notice  
 
    Change of Director`s Interest Notice  
 
    Appointment of a Director  
 
    Change in substantial holding  
 
    Appendix 3B  
 
    Results of General Meeting  
 
    Presentation to General Meeting  
 
    Change in substantial holding  
 
    Shareholders` Meeting to Approve the TUTA Acquisition  
 
    Half Yearly Report and Accounts  
 
    TUTA Healthcare Acquisition and $1.0M Underwritten Placement  
 
    Appendix 4C - quarterly  
 
    Change in substantial holding  
 
    Appendix 3B  
 
    Activities Update  
 
    Change in substantial holding  
 
    Results of AGM  
 
    Presentation to AGM  
 
    Appendix 4C - quarterly  
 
    Product Launch int the UK and Eurpoe  
 
    30 June 2007 Annual Report and Notice of AGM  
 
    Preliminary Final Report  
 
    Appendix 4C - quarterly  
 
    USA FDA Registration for IMD Safety Syringes  
 
    Company Activity Update  
 
    Change of Director`s Interest Notice  
 
    Change in substantial holding  
 
    Change in substantial holding  
 
    Change of Director's Interest Notice  
 
    Change in substantial holding  
 
    Appendix 3B  
 
    Commitments Test Entity - Third Quarter Report  
 
    Change of Director's Interest Notice  
 
    Change of Director's Interest Notice  
 
    Appointment of Managing Director  
 
    Half Yearly Report & Half Year Accounts  
 
    Becoming a substantial holder  
 
    Commercial Ready Grant  
 
    Change of Director's Interest Notice  
 
    Becoming a substantial holder  
 
    Becoming a substantial holder  
 
    Becoming a substantial holder  
 
    Change of Director's Interest Notice  
 
    Commitments Test Entity - Second Quarter Report  
 
    Appendix 3B  
 
    Release of Escrow Shares  
 
    Results of Meeting  
 
    Presentation to AGM  
 
    Director Appointment/Appendix 3X  
 
    Response to ASX Query re: Appendix 4C  
 
    Commitments Test Entity - First Quarter Report  
 
    30 June 2006 Annual Report and Notice of AGM/Proxy Form  
 
    Preliminary Final Report  
 
    Supply Agreement with Terumo Corporation  
 
    Long Term Contract with UNICEF  
 
    Commitments Test Entity - Fourth Quarter Report  
 
    Agreement with USA Medical devices Company  
 
    Change of Director's Interest Notice x 2  
 
    Appendix 3B  
 
    Details of IMD Group Limited Share Purchase Plan  
 
    Commercialisation of Auto Retractable Syringe  
 
    Share Purchase Plan  
 
    Appendix 3B  
 
    Commitments Test Entity - Third Quarter Report  
 
    First USA and European Sales & Appointment of Distributors  
 
    Half Year Accounts  
 
    Half Yearly Report  
 
    TGA Approval for Manual Retractable Safety Syringe  
 
    Director Resignation & Appointment/Appendix 3Z/3X  
 
    Commitments Test Entity - Second Quarter Report  
 
    Director Resignation  
 
    Results of Meeting  
 
    Presentation to AGM  
 
    Commitments Test Entity - First Quarter Report  
 
    Secures first Middle East Order of Medical Consumables  
 
    Annual Report and Notice of AGM  
 
    Appendix 3B  
 
    Preliminary Final Report - Appendix 4E 30 June 2005  
 
    Release of Escrow Shares  
 
    Commitments Test Entity - Fourth Quarter Report  
 
    Response to ASX Query re Share Price  
 
    Succession of General Manager to CEO  
 
    Letter to Shareholders: Update  
 
    Expansion of Product Range & TGA Approval  
 
    Australian Distribution Agreement  
 
    Commitments Test Entity - Third Quarter Report  
 
    Product Sales in India  
 
    Half Year Accounts  
 
    Half Yearly Report  
 
    Expansion of Safety Syringe Product Range  
 
    Canadian Regulatory Approval  
 
    Chinese Distribution Agreement  
 
    Commitments Test Entity - Second Quarter Report  
 
    TGA Approval  
 
    Initial Director's Interest Notice x4  
 
    Expansion of FDA & CE Mark approved product range  
 
    Investigation Accountant's Rep-Pro Forma Historical Fin Info  
 
    Top 20 shareholders/Reviewed Pro forma Balance Sheet  
 
    Distribution Schedule  
 
    Market Release: Pre-Quotation Disclosure  
 
    Commencement of Official Quotation  
 
    Admission to Official List  
 
    Constitution  
 
    Appendix 1A - ASX Listing application & agreement  
 
    Disclosure Document